Yellow fever vaccine,vial of 10 doses

General Description:
Yellow fever vaccine, vial of 10 doses

An attenuated live virus vaccine containing freeze-dried attenuated virus from the 17D strain produced in eggs.

For information on product specifications, refer to the WHO website on Prequalified Vaccines.

https://www.who.int/immunization_standards /vaccine_quality/PQ_vaccine_list_en/en/

Administration:
The vaccine is for the active immunization of adults and children from the age of six months against yellow fever. A 0.5ml dose of vaccine should be administered intramuscularly or deep subcutaneously, preferably in the upper arm. A sterile needle and sterile syringe should be used for each injection.

Because of sensitivity to ultraviolet light, the vaccine must be protected from sunlight. Once the vaccine has been reconstituted, it should be used the same day (preferably immediately but by no means beyond six hours after reconstitution), and only then if the vial has been maintained between +2°C and +8°C and protected from sunlight. If not used immediately after reconstitution, the vaccine should be kept on ice to maintain its temperature between +2°C and +8°C. Any opened container remaining at the end of a session (within six hours of reconstitution) should be discarded. The vaccine vial monitor if present would be removed on reconstitution.

The diluent supplied by the manufacturer is specially designed for use with this vaccine. Only this diluent may be used to reconstitute the vaccine. Do not use diluents from other types of vaccine or from other manufacturers. Water for injection may NOT be used for this purpose. Using an incorrect diluent may result in damage to the vaccine and/or serious reactions to those receiving the vaccine. Diluent must not be frozen but must be cooled between +2°C and +8°C before reconstitution. The vaccine should not be reconstituted with another vaccine.

Immunization Schedule:
In countries where yellow fever poses a risk for children, the vaccine is given as soon as possible after 6 months (180 days) of age. Most countries administer yellow fever vaccine at 9 months of age at the same visit as measles vaccine. Yellow fever vaccine can also be given safely and effectively at the same visit as DT, Td, TT, BCG, polio (OPV and IPV), hepatitis B, and haemophilus influenzae type b vaccines and vitamin A supplementation. A single dose of vaccine provides protection for at least 30 years, and probably for life in most recipients.

When administered for purposes of the International Certificate of Vaccination, a dose of yellow fever vaccine is valid for a period of 10 years, starting 10 days after the date of immunization.

Transport and Storage:
The vaccine should be transported and stored at +2°C to +8°C.
The vials of vaccine and the diluents should be stored and transported together.